CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

被引：0
|
作者：
Heike Israel
Lars Neeb
Uwe Reuter
机构：
[1] Charité Headache Center,Charité Universitätsmedizin Berlin, Department of Neurology
来源：
Current Pain and Headache Reports | 2018年 / 22卷
关键词：
Chronic migraine; Episodic migraine; CGRP antibody; Migraine prevention; Antibody safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CGRP antibodies in the prophylactic treatment of migraine
    Sipkova, J.
    Nezadal, T.
    Ctrnacta, D.
    Bajacek, M.
    Dvorak, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (03) : 248 - 256
  • [22] Optimization of Acute Treatment in Migraine Patients Treated with Monoclonal Antibodies Acting on the CGRP Pathway
    Rosignoli, C.
    Ornello, R.
    Caponnetto, V.
    Onofri, A.
    Tartaglione, L.
    Russo, A.
    Silvestro, M.
    Sacco, S.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [23] Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies
    Khodavirdi, Ani C.
    Multani, Jasjit K.
    Oh, Sam S.
    Vuvu, Fiston
    Bensink, Mark E.
    Stockl, Karen M.
    Hawkins, Kevin
    Chiang, Chia-Chun
    Green, A. Laine
    Tepper, Stewart J.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [24] Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies
    Vashchenko, N.
    Skorobogatykh, K.
    Azimova, J.
    Korobkova, D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 122 - 122
  • [25] Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
    Negro, Andrea
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 769 - 776
  • [26] CGRP monoclonal antibodies in the treatment of migraine - indication criteria and therapeutic recommendations for the Czech Republic
    Nezadal, T.
    Markova, J.
    Bartkova, A.
    Klecka, L.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (04) : 445 - 451
  • [27] Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials
    Silvestro, Marcello
    Orologio, Ilaria
    Siciliano, Mattia
    Trojsi, Francesca
    Tessitore, Alessandro
    Tedeschi, Gioacchino
    Russo, Antonio
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (02) : 79 - 96
  • [28] Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine
    Van der Arend, Britt W. H.
    Van Veelen, Nancy
    De Ruijter, Joelle E. T.
    Olsen, Michael H.
    MaassenVanDenBrink, Antoinette
    Terwindt, Gisela M.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [29] Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies
    Vashchenko, N.
    Skorobogatykh, K.
    Azimova, J.
    Korobkova, D.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 182 - 182
  • [30] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Hugo Sevivas
    Paula Fresco
    European Journal of Medical Research, 27
12345